Natural history of moderate aplastic anemia in children

被引:41
作者
Howard, SC
Naidu, PE
Hu, XJ
Jeng, MR
Rodriguez-Gallindo, C
Rieman, MD
Wang, WC
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Univ Memphis, Dept Math Sci, Memphis, TN 38152 USA
关键词
bone marrow failure; moderate aplastic anemia; natural history; pediatric;
D O I
10.1002/pbc.20131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Moderate aplastic anemia (MAA) in children is a rare, idiopathic condition of bone marrow insufficiency that can resolve spontaneously, persist for months or years, or progress to severe aplastic anemia (SAA). We evaluated the rate of progression to SAA. Methods. We reviewed the records of 136 children referred for evaluation of bone marrow failure from 1978 to 2002 at St. Jude Children's Research Hospital. MAA was defined by a hypo-cellular bone marrow (<50%) and 2 or 3 cytopenias (absolute neutrophil count <1,500/mm(3), absolute reticulocyte count <40,000/mm(3), platelet count <100,000/mm(3)) lasting at least 6 weeks. Results. Twenty-four patients met the criteria for MAA. At a median follow-up of 66 months (range, 10-293), 16 patients (67%) progressed to SAA, 5 (21%) had persistent MAA, and 3 (12%) had complete resolution of MAA. No risk factors for progression could be identified. Conclusions. When childhood MAA is treated with supportive care alone, 2/3 of patients progress to SAA. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:545 / 551
页数:7
相关论文
共 27 条
  • [1] Abdulkadyrov K M, 1995, Lik Sprava, P16
  • [2] AGGIO MC, 1988, MEDICINA-BUENOS AIRE, V48, P231
  • [3] Aplastic anemia and immune-mediated thrombocytopenia: Concurrent complications encountered in the third trimester of pregnancy
    Ascarelli, MH
    Emerson, ES
    Bigelow, CL
    Martin, JN
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (05) : 803 - 806
  • [4] Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients
    Bacigalupo, A
    Bruno, B
    Saracco, P
    Di Bona, E
    Locasciulli, A
    Locatelli, F
    Gabbas, A
    Dufour, C
    Arcese, W
    Testi, G
    Broccia, G
    Carotenuto, M
    Coser, P
    Barbui, T
    Leoni, P
    Ferster, A
    [J]. BLOOD, 2000, 95 (06) : 1931 - 1934
  • [5] APLASTIC-ANEMIA .2. PATHOGENESIS, DIAGNOSIS, TREATMENT, AND PROGNOSIS
    CAMITTA, BM
    STORB, R
    THOMAS, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (12) : 712 - 718
  • [6] FREEDMAN MH, 1990, AM J PEDIAT HEMATOL, V12, P383
  • [7] Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia
    Frickhofen, N
    Heimpel, H
    Kaltwasser, JP
    Schrezenmeier, H
    [J]. BLOOD, 2003, 101 (04) : 1236 - 1242
  • [8] Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine
    Frickhofen, N
    Rosenfeld, SJ
    [J]. SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 56 - 68
  • [9] TREATMENT OF APLASTIC-ANEMIA WITH ANTILYMPHOCYTE GLOBULIN AND METHYLPREDNISOLONE WITH OR WITHOUT CYCLOSPORINE
    FRICKHOFEN, N
    KALTWASSER, JP
    SCHREZENMEIER, H
    RAGHAVACHAR, A
    VOGT, HG
    HERRMANN, F
    FREUND, M
    MEUSERS, P
    SALAMA, A
    HEIMPEL, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) : 1297 - 1304
  • [10] CURRENT CONSIDERATIONS OF THE ETIOLOGY OF APLASTIC-ANEMIA
    GEWIRTZ, AM
    HOFFMAN, R
    [J]. CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1985, 4 (01): : 1 - 30